Experts highlight ten common requests received in their Gastroenterology advice and guidance service and explain how these ...

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the first quarter of 2025, along with recent ...

derived from the roundleaf bat hepatitis B virus core antigen (RBHBcAg); the candidate molecule was named CR-T3-SEQ13. Multiple copies of epitopes on the surface of this particulate antigen promote ...

Polyclonal rabbit anti-Hepatitis B virus core antigen (HBc) antibody (B0586) was purchased from the Dako (Glostrup, Denmark), polyclonal rabbit anti-HBsAg antibody (NB100-62652) from Novus Biological ...

Objective Hepatitis B virus (HBV) can integrate into the chromosomes of infected hepatocytes, contributing to the production of hepatitis B surface antigen (HBsAg ... evaluate the expression of HBsAg ...

Vir Biotechnology’s sidelined hepatitis B candidate, designed to serve as a “functional cure,” has failed to achieve the ...

The Hepatitis B virus is a leading cause of liver-related morbidity and mortality, particularly through chronic hepatitis B (CHB), which can progress to cirrhosis and liver cancer. While most ...

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the lower limit of detection (LLOD), is associated with better clinical outcomes of ...

Discover a recent study presented at EASL 2025 that explored the impact of opt-out testing for blood-borne viruses in ...